<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">Antiphospholipid syndrome</z:e> (APS) is an <z:hpo ids='HP_0002960'>autoimmune disease</z:hpo> characterized clinically by the occurrence of venous or <z:hpo ids='HP_0004420'>arterial thrombosis</z:hpo>, and/or pregnancy morbidity </plain></SENT>
<SENT sid="1" pm="."><plain>The detection of persistently elevated levels of <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> (aPL) is a requisite laboratory feature for the diagnosis of APS </plain></SENT>
<SENT sid="2" pm="."><plain>The positivity for at least one aPL test: <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> and/or IgG/IgM anticardiolipin and/ or IgG/IgM anti-β2 glycoprotein I antibodies must be detected </plain></SENT>
<SENT sid="3" pm="."><plain>Sometimes aPL <z:hpo ids='HP_0003256'>coagulopathy</z:hpo> may start with a hemorrhagic syndrome when a severe <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo>, or an <z:e sem="disease" ids="C1264032" disease_type="Disease or Syndrome" abbrv="">acquired thrombocytopathy</z:e>, or an acquired factor VIII inhibitor, or an <z:e sem="disease" ids="C0392610" disease_type="Disease or Syndrome" abbrv="">acquired prothrombin deficiency</z:e> is present </plain></SENT>
<SENT sid="4" pm="."><plain>aPL-associated <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo> is usually moderate without clinical manifestations </plain></SENT>
<SENT sid="5" pm="."><plain>Except in the occasional situations in which <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo> is associated with <z:e sem="disease" ids="C0034155" disease_type="Disease or Syndrome" abbrv="">thrombotic microangiopathy</z:e>, such as catastrophic APS, <z:mp ids='MP_0001914'>bleeding</z:mp> is uncommon in APS patients </plain></SENT>
<SENT sid="6" pm="."><plain>When platelet counts are less than 30 × 109/L and there are symptoms of <z:mp ids='MP_0001914'>bleeding</z:mp>, the treatments used are the same for <z:hpo ids='HP_0001973'>idiopathic thrombocytopenic purpura</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain>In rare occasions a <z:e sem="disease" ids="C0019087" disease_type="Disease or Syndrome" abbrv="">hemorrhagic diathesis</z:e> due to the occurrence of non-neutralizing anti-prothrombin antibodies causing severe <z:e sem="disease" ids="C0020640" disease_type="Disease or Syndrome" abbrv="">hypoprothrombinemia</z:e> (HPT) can be observed </plain></SENT>
<SENT sid="8" pm="."><plain>Levels of prothrombin in plasma are less than 10-20% in cases with HPT-related <z:mp ids='MP_0001914'>bleeding</z:mp> requiring transfusion and/or <z:chebi fb="0" ids="50858">corticosteroid</z:chebi> treatment </plain></SENT>
<SENT sid="9" pm="."><plain>The APS mainly causes <z:mp ids='MP_0005048'>thrombosis</z:mp>, and pregnancy losses </plain></SENT>
<SENT sid="10" pm="."><plain>However, other clinical manifestations are also associated with the presence of persistent autoimmune aPL </plain></SENT>
<SENT sid="11" pm="."><plain><z:mp ids='MP_0001914'>Bleeding</z:mp> is uncommon but can be the first clinical manifestation in patients having severe <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo> or <z:e sem="disease" ids="C0020640" disease_type="Disease or Syndrome" abbrv="">prothrombin deficiency</z:e> </plain></SENT>
</text></document>